L-lysyl-l-arginine

DB19436InvestigationalSmall molecule

L-lysyl-l-arginine is under investigation in clinical trial NCT03972488 (Study to Evaluate the Efficacy and Safety of Lutathera in Patients With Grade 2 and Grade 3 Advanced GEP-NET).

Chemical structure of L-lysyl-l-arginine
Formula / weight
C12H26N6O3 · 302.379 g/mol (avg)
Also known as
(2s)-2-(((2s)-2,6-bis(azanyl)hexanoyl)amino)-5-carbamimidamido-pentanoic acid · L-arginine, l-lysyl- · Lys-arg

Resolves to

Compound
UNIIHX25W9VLX3CAS29586-66-1ChEMBLCHEMBL380183ChEBI74553PubChem15061422
Structure
InChIKeyNPBGTPKLVJEOBE-IUCAKERBSA-NSMILESNCCCC[C@H](N)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O

What you can answer from here — as of September 23, 2026

1Clinical trialPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which companies are running trials of L-lysyl-l-arginine, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In